Ras/Raf1-dependent signal in sphingosine-1-phosphate-induced tube formation in human coronary artery endothelial cells

Biochemical and Biophysical Research Communications

Volumn 306, Issue 4, 2003, Pages 924-929

  Miura, Shin Ichiro ^a   Tanigawa, Hiroyuki ^a   Matsuo, Yoshino ^a   Fujino, Masahiro ^a   Kawamura, Akira ^a   Saku, Keijiro ^a  

^a FUKUOKA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Extracellular signal activated kinase; Human coronary artery endothelial cell; Pertussis toxin; Ras; Sphingosine 1 phosphate

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; ENZYME; EXTRACELLULAR SIGNAL ACTIVATED KINASE; G PROTEIN COUPLED RECEPTOR; HIGH DENSITY LIPOPROTEIN; PERTUSSIS TOXIN; RAF PROTEIN; RAS PROTEIN; SPHINGOSINE 1 PHOSPHATE; UNCLASSIFIED DRUG;

ARTICLE; CLINICAL PATHWAY; CONTROLLED STUDY; CORONARY ARTERY; DRUG ACTIVITY; DRUG EFFECT; DRUG INHIBITION; ENDOTHELIUM CELL; ENZYME ACTIVATION; EVALUATION; HUMAN; HUMAN CELL; IN VITRO STUDY; MODEL; PHARMACOLOGICAL BLOCKING; PRIORITY JOURNAL; PROTEIN DETERMINATION; SIGNAL TRANSDUCTION; TUBE;

EID: 0038772091     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-291X(03)01065-9     Document Type: Article

References (20)

1. Kluk M.J., Hla T. Signaling of sphingosine-1-phosphate via the S1P/EDG-family of G-protein-coupled receptors. Biochim. Biophys. Acta. 1582:2002;72-80.
2. Dimmeler S., Zeiher A.M. Endothelial cell apoptosis in angiogenesis and vessel regression. Circ. Res. 87:2000;434-439.
3. Lee M.J., Thangada S., Claffey K.P., Ancellin N., Liu C.H., Kluk M., Volpi M., Sha'afi R.I., Hla T. Vascular endothelial cell adherens junction assembly and morphogenesis induced by sphingosine-1-phosphate. Cell. 99:1999;301-312.
4. Lee M.J., Thangada S., Paik J.H., Sapkota G.P., Ancellin N., Chae S.S., Wu M., Morales-Ruiz M., Sessa W.C., Alessi D.R., Hla T. Akt-mediated phosphorylation of the G protein-coupled receptor EDG-1 is required for endothelial cell chemotaxis. Mol. Cell. 8:2001;693-704.
5. Lysophosphatidylcholine inhibits endothelial cell migration and proliferation via inhibition of the extracellular signal-regulated kinase pathway. Arterioscler. Thromb. Vasc. Biol. 22 (2002) 108-114.
6. Rak J., Kerbel R.S. Ras regulation of vascular endothelial growth factor and angiogenesis. Methods Enzymol. 333:2001;267-283.
7. Meadows K.N., Bryant P., Pumiglia K. Vascular endothelial growth factor induction of the angiogenic phenotype requires Ras activation. J. Biol. Chem. 276:2001;29289-29298.
8. Miura S., Fujino M., Matsuo Y., Kawamura A., Tanigawa H., Nishikawa H., Saku K. High density lipoprotein-induced angiogenesis requires the activation of Ras/MAP kinase in human coronary artery endothelial cells. Arterioscler. Thromb. Vasc. Biol. 23:2003;802-808.
9. Miura S., Matsuo Y., Saku K. Transactivation of KDR/Flk-1 by the B2 receptor induces tube formation in human coronary endothelial cells. Hypertension. 41:2003;1118-1123.
10. Kleinman H.K., McGarvey M.L., Hassell J.R., Star V.L., Cannon F.B., Laurie G.W., Martin G.R. Basement membrane complexes with biological activity. Biochemistry. 25:1986;312-318.
11. Miura S., Karnik S.S., Ligand-independent signals from angiotensin II type 2 receptor induce apoptosis EMBO J. 19:2000;4026-4035.
12. Sun J., Qian Y., Hamilton A.D., Sebti S.M. Both farnesyltransferase and geranylgeranyltransferase I inhibitors are required for inhibition of oncogenic K-Ras prenylation but each alone is sufficient to suppress human tumor growth in nude mouse xenografts. Oncogene. 16:1998;1467-1473.
13. Roovers K., Assoian R.K. Integrating the MAP kinase signal into the G1 phase cell cycle machinery. Bioessays. 22:2000;818-826.
14. Pang L., Sawada T., Decker S.J., Saltiel A.R. Inhibition of MAP kinase kinase blocks the differentiation of PC-12 cells induced by nerve growth factor. J. Biol. Chem. 270:1995;13585-13588.
15. Kerbel R.S., Viloria-Petit A., Klement G., Rak J. 'Accidental' anti-angiogenic drugs: anti-oncogene directed signal transduction inhibitors and conventional chemotherapeutic agents as examples. Eur. J. Cancer. 36:2000;1248-1257.
16. Nofer J.R., Levkau B., Wolinska I., Junker R., Fobker M., von Eckardstein A., Seedorf U., Assmann G. Suppression of endothelial cell apoptosis by high density lipoproteins (HDL) and HDL-associated lysosphingolipids. J. Biol. Chem. 276:2001;34480-34485.
17. Takuwa Y. Subtype-specific differential regulation of Rho family G proteins and cell migration by the EDG family sphingosine-1-phosphate receptors. Biochim. Biophys. Acta. 1582:2002;112-120.
18. 2+ mobilization, Ras-mitogen-activated protein kinase activation, and adenylate cyclase inhibition. J. Biol. Chem. 273:1998;27104-27110.
19. Isner J.M., Losordo D.W. Therapeutic angiogenesis for heart failure. Nat. Med. 5:1999;491-492.
20. Kahlon R., Shapero J., Gotlieb A.I. Angiogenesis in atherosclerosis. Can. J. Cardiol. 8:1992;60-64.